RobertLConwayMD

Medical Genetics • Grand Rapids, MI

Clinical Biochemical Genetics, Clinical Genetics

Clinical and Biochemical Geneticist Helen Devos Children's Hospital, Spectrum Health

Join to view full profile

Dr. Conway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Conway's full profile

Already have an account?

Office
35 Michigan St NE
Ste 3003
Grand Rapids, MI 49503
Phone+1 616-486-9830

Education & Training

Cedars-Sinai Medical CenterResidency, Medical Genetics and Genomics, 2004 - 2006
Indiana University School of MedicineResidency, Pediatrics, 2001 - 2004
University of California San Diego School of MedicineClass of 2001

Certifications & Licensure

CA State Medical License 2004 - Present
MI State Medical License 2007 - 2026
ND State Medical License 2024 - 2025
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Clinical Trials

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Start of enrollment: 2014 Dec 31
Completed
Phase 4

Publications & Presentations

PubMed

516 citations
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
Jean Baptiste Rivière, Ghayda M. Mirzaa, Brian J. O'Roak, Margaret Beddaoui, Diana Alcantara
Nature Genetics. 2012-08-01
127 citations
PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution
Ghayda M. Mirzaa, Andrew E. Timms, Valerio Conti, Evan A. Boyle, Katta M. Girisha
JCI Insight. 2016-06-16
29 citations
An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions.
Areeg El-Gharbawy, Joanne Mackey, Stephanie DeArmey, Greg Westby, Sherry G. Grinnell
Molecular Genetics and Metabolism. 2011-09-01